Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$COLL Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.46 down -221.05% YoY • Reported revenue of $199.88M up 6.32% YoY • Collegium Pharmaceutical updated its full-year 2026 guidance, now expecting product revenues between $825 million and $855 million and adjusted EBITDA between $445 million and $470 million for the full year.

Price since post

Full Details

Advertisement|Remove ads.